At a glance
- Originator National Institutes of Health (USA)
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Glutamate receptor antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 05 Feb 1999 Discontinued-I for Epilepsy in France (Unknown route)
- 01 Sep 1997 Phase-I clinical trials for Epilepsy in France (Unknown route)